TY - JOUR
T1 - Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients
T2 - A double-blind randomized echo-doppler study
AU - Buonamico, Paolo
AU - Sabba, Carlo
AU - Garcia-Tsao, Guadalupe
AU - Berardi, Elsa
AU - Antonica, Gianfranco
AU - Ferraioli, Giovanna
AU - Jensen, Jonathan E.
AU - Lerner, Emanuel
AU - Taylor, Kenneth J W
AU - Albano, Ottavio
AU - Groszmann, Roberto J.
PY - 1995
Y1 - 1995
N2 - The effect of octreotide, a long-acting synthetic analog of somatostatin, on fasting and postprandial splanchnic hemodynamics was investigated in cirrhotic patients. Splanchnic hemodynamics were assessed using an echo-Doppler duplex system in a prospective, double-blind, placebo-controlled, crossover study performed on 2 separate days, 1 week apart, in 30 cirrhotic patients. Measurements of portal vein (PV) cross-sectional area (PVA) and mean velocity (PV-V), and of superior mesenteric artery (SMA) mean velocity (SMA-V) and pulsatility index (SMA-PI) (an index of vascular resistance) were performed at baseline, 30 minutes after octreotide (200 μg subcutaneously) or placebo administration, and 30 and 60 minutes after the ingestion of a liquid meal. In the fasted state, octreotide induced a significant decrease in PV-V (-7%) and in SMA-V (-10%) and an increase in PI (+16%). On the day of placebo administration, meal ingestion induced a significant increase in PV-V (+21%) and in SMA-V (+43%) and a decrease in PI (-21%). In contrast, meal ingestion on octreotide day induced significantly smaller increases in PV-V (+10%) and in SMAV (+18%) and a significantly smaller decrease in PI (-10%). Octreotide, although producing a mild reduction in PV-V and SMA-V in the fasted state, markedly blunts postprandial splanchnic hyperemia in cirrhotic patients.
AB - The effect of octreotide, a long-acting synthetic analog of somatostatin, on fasting and postprandial splanchnic hemodynamics was investigated in cirrhotic patients. Splanchnic hemodynamics were assessed using an echo-Doppler duplex system in a prospective, double-blind, placebo-controlled, crossover study performed on 2 separate days, 1 week apart, in 30 cirrhotic patients. Measurements of portal vein (PV) cross-sectional area (PVA) and mean velocity (PV-V), and of superior mesenteric artery (SMA) mean velocity (SMA-V) and pulsatility index (SMA-PI) (an index of vascular resistance) were performed at baseline, 30 minutes after octreotide (200 μg subcutaneously) or placebo administration, and 30 and 60 minutes after the ingestion of a liquid meal. In the fasted state, octreotide induced a significant decrease in PV-V (-7%) and in SMA-V (-10%) and an increase in PI (+16%). On the day of placebo administration, meal ingestion induced a significant increase in PV-V (+21%) and in SMA-V (+43%) and a decrease in PI (-21%). In contrast, meal ingestion on octreotide day induced significantly smaller increases in PV-V (+10%) and in SMAV (+18%) and a significantly smaller decrease in PI (-10%). Octreotide, although producing a mild reduction in PV-V and SMA-V in the fasted state, markedly blunts postprandial splanchnic hyperemia in cirrhotic patients.
UR - http://www.scopus.com/inward/record.url?scp=0028874266&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028874266&partnerID=8YFLogxK
U2 - 10.1016/0270-9139(95)90420-4
DO - 10.1016/0270-9139(95)90420-4
M3 - Article
C2 - 7806146
AN - SCOPUS:0028874266
VL - 21
SP - 134
EP - 139
JO - Hepatology
JF - Hepatology
SN - 0270-9139
IS - 1
ER -